Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
AREN1921: Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Badgett, James
(PI)
Pediatrics
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Wilms' Tumor
100%
Histology
100%
Irinotecan
5%
Long Term Survival
5%
Carboplatin
5%
Survival Rate
5%
Clinical Trial
5%
Vincristine
5%
Topotecan
5%
Etoposide
5%
Ifosfamide
5%
Cyclophosphamide
5%
Chemotherapy
5%
Spine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Nephroblastoma
100%
Etoposide
5%
Cyclophosphamide
5%
Irinotecan
5%
Clinical Trial
5%
Ifosfamide
5%
Long Term Survival
5%
Survival Rate
5%
Vincristine
5%
Carboplatin
5%
Topotecan
5%
Chemotherapy Regimens
5%